SpeakerJudy Pa (Assistant Professor of Neurology)
Date and LocationOctober 06, 2017 11:00am
Alzheimer’s disease is the most common cause of cognitive impairment in older adults. Over 5 million people in the US are affected, and this number is expected to triple by 2050. There is a need to approach this crisis from both a prevention and treatment perspective. Our work is grounded in a 2-pronged approach for identifying early novel biomarkers of risk for cognitive decline and developing effective interventions for secondary prevention in those who exhibit heightened risk. I will first discuss our research aimed at understanding the underlying phenotypes of risk associated with gender and genetics, followed by ongoing clinical interventions aimed at enhancing brain function and structure.